Skip to main content

Table 1 Baseline characteristics of patients by serum Sodium concentration (mmol/L) in the Irish Health System

From: Impact of serum sodium concentrations, and effect modifiers on mortality in the Irish Health System

 

Serum Sodium Category

P -value

Variable

N

 < 135 mmol/L

135–145 mmol/L

 > 145 mmol/L

Observations n (%)

32,666

2503 (7.7)

29,908 (91.6)

255 (0.8)

 

Mean Age at baseline (SD)

32,666

65.9 (16.8)

56.1 (17.9)

63.3 (18.3)

 < 0.001

Sex

 Women

17,367

48.8

53.6

44.7

 

 Men

15,299

51.2

46.4

55.3

 < 0.001

Clinical setting at baseline a

 Emergency Department

4,835

30.1

13.5

16.9

 

 General Practice

15,293

19.7

49.4

21.2

 

 Inpatient

7,543

37.7

21.6

56.1

 

 Outpatient

4,965

12.5

15.5

5.9

 < 0.001

Markers of renal function

 Urea (mmol/L) (Median IQR)

32,666

5.3 (3.8–8.2)

4.9 (3.8–6.2)

7.9 (5.2–14.1)

 < 0.001

 Serum creatinine (µmol/L) (Median IQR)

32,666

81.0 (64.0–108.0)

77.0 (65.0–91.0)

97.0 (78.0–140.0)

 < 0.001

 Baseline eGFR b (ml/min/1.73m2) (Median IQR)

32,666

76.5 (50.9–93.6)

86.4 (68.5–101.2)

63.1 (36.3–86.7)

 < 0.001

eGFR Category (ml/min/1.73m2) b

 eGFR >  = 90

13,882

30.1

43.7

20.8

 

 eGFR 60–89

12,867

36.8

39.7

33.7

 

 eGFR 30–59

4,755

21.9

13.8

29.8

 

 eGFR 15–29

814

7

2

11.8

 

 eGFR < 15

348

4.4

0.8

3.9

 < 0.001

Inflammatory Markers

 Haemoglobin (g/dl) (Mean SD)

26,561

12.4 (2.1)

13.5 (1.8)

12.4 (2.5)

 < 0.001

 White blood count (× 109/L) (Median IQR)

26,561

9.2 (6.7–12.7)

7.2 (5.8–9.4)

10.5 (7.2–15.0)

 < 0.001

 Lymphocyte count (× 109/L) (Median IQR)

26,561

1.2 (0.8–1.7)

1.7 (1.3–2.2)

1.3 (0.8–1.9)

 < 0.001

 Neutrophil count (× 109/L) (Median IQR)

26,561

6.8 (4.4–10.4)

4.4 (3.3–6.3)

8.4 (4.7–12.3)

 < 0.001

Nutritional and Metabolic Markers

 Serum Albumin (g/L) (Mean SD)

32,666

32.6 (7.3)

37.7 (5.5)

29.7 (9.5)

 < 0.001

 Serum Calcium (mmol/L) (Mean SD)

32,666

2.2(0.2)

2.3 (0.1)

2.2 (0.3)

 < 0.001

 Serum Phosphorus (mmol/L) (Mean SD)

32,666

1.2(0.4)

1.2 (0.3)

1.2 (0.5)

 < 0.001

 Serum Potassium (mmol/L) (Mean SD)

32,666

4.3(0.8)

4.4 (0.5)

4.1 (0.8)

 < 0.001

Lipid related Markers

 Total Cholesterol (mmol/L) (Mean SD)

17,188

4.7 (1.3)

5.1 (1.1)

4.9 (1.2)

 < 0.001

 Triglycerides (mmol/L) (Mean SD)

14,302

1.3 (1.1)

1.4 (0.9)

1.6 (1.2)

 < 0.001

Glycaemic markers

 Glucose (mmol/L) (Median IQR)

32,666

6.6 (5.4–10.1)

5.2 (4.8–6.1)

6.2 (5.2–8.0)

 < 0.001

Markers of Liver function

 Alanine Alkaline phosphatase (IU/L) (Median IQR)

31,599

79.0 (61.0–105.0)

68.0 (55.0–84.0)

75.0 (57.2–97.0)

 < 0.001

 Alanine transaminase (IU/L) (Median IQR)

31,131

23.0 (17.0–35.0)

23.0 (17.0–32.0)

24.0 (18.0–42.0)

0.018

 Gamma-glutamyltransferase (IU/L) (Median IQR)

31,196

34.0 (21.0–67.0)

24.0 (17.0–39.0)

31.0 (21.0–70.0)

 < 0.001

 Total bilirubin (µmol/L) (Median IQR)

30,867

13.0 (10.0–19.0)

12.0 (9.0–16.0)

14.0 (10.0–21.0)

 < 0.001

  1. aClinical setting at baseline refers to the clinical location of patient where the laboratory test was taken
  2. beGFR: Estimated glomerular filtration rate (ml/min per 1.73 m2) was based on the Chronic Kidney Disease Collaborative (CKD-EPI) [18].